High-density and targeted glycoproteomic profiling of serum proteins in pancreatic cancer and intraductal papillary mucinous neoplasm

References

• Carrato A, Falcone A, Ducreux M, et al. A systematic review of the burden of pancreatic cancer in Europe: real-world impact on survival, quality of life and costs. J Gastrointest Canc. 2015;46:201–211.
   PubMedGoogle Scholar
• Ansari D, Bauden M, Bergstrom S, et al. Relationship between tumour size and outcome in pancreatic ductal adenocarcinoma. Br J Surg. 2017;104:600–607.
   PubMed Web of Science ®Google Scholar
• Ansari D, Tingstedt B, Andersson B, et al. Pancreatic cancer: yesterday, today and tomorrow. Future Oncol. 2016;12:1929–1946.
   PubMed Web of Science ®Google Scholar
• Huang L, Jansen L, Balavarca Y, et al. Resection of pancreatic cancer in Europe and USA: an international large-scale study highlighting large variations. Gut. 2017. DOI:10.1136/gutjnl-2017-314828
   Web of Science ®Google Scholar
• Neoptolemos JP, Palmer DH, Ghaneh P, et al. Comparison of adjuvant gemcitabine and capecitabine with gemcitabine monotherapy in patients with resected pancreatic cancer (ESPAC-4): a multicentre, open-label, randomised, phase 3 trial. Lancet. 2017;389:1011–1024.
   PubMed Web of Science ®Google Scholar
• Aronsson L, Andersson R, Ansari D. Intraductal papillary mucinous neoplasm of the pancreas - epidemiology, risk factors, diagnosis, and management. Scand J Gastroenterol. 2017;52:803–815.
   PubMed Web of Science ®Google Scholar
• Lennon AM, Wolfgang CL, Canto MI, et al. The early detection of pancreatic cancer: what will it take to diagnose and treat curable pancreatic neoplasia? Cancer Res. 2014;74:3381–3389.
   PubMed Web of Science ®Google Scholar
• Duffy MJ, Sturgeon C, Lamerz R, et al. Tumor markers in pancreatic cancer: a European Group on Tumor Markers (EGTM) status report. Ann Oncol. 2010;21:441–447.
   PubMed Web of Science ®Google Scholar
• European Study Group on Cystic Tumours of the Pancreas. European evidence-based guidelines on pancreatic cystic neoplasms. Gut. 2018;67:789–804.
   PubMed Web of Science ®Google Scholar
• Apweiler R, Hermjakob H, Sharon N. On the frequency of protein glycosylation, as deduced from analysis of the SWISS-PROT database. Biochim Biophys Acta. 1999;1473:4–8.
   PubMed Web of Science ®Google Scholar
• Rodrigues JG, Balmana M, Macedo JA, et al. Glycosylation in cancer: Selected roles in tumour progression, immune modulation and metastasis. Cell Immunol. 2018. DOI:10.1016/j.cellimm.2018.03.007
   Web of Science ®Google Scholar
• Pinho SS, Reis CA. Glycosylation in cancer: mechanisms and clinical implications. Nat Rev Cancer. 2015;15:540–555.
   PubMed Web of Science ®Google Scholar
• Pan S, Brentnall TA, Chen R. Glycoproteins and glycoproteomics in pancreatic cancer. World J Gastroenterol. 2016;22:9288–9299.
   PubMed Web of Science ®Google Scholar
• Krishnan S, Whitwell HJ, Cuenco J, et al. Evidence of altered glycosylation of serum proteins prior to pancreatic cancer diagnosis. Int J Mol Sci. 2017;18:2670.
   Web of Science ®Google Scholar
• Brierley J, Gospodarowicz M, Wittekind C. TNM classification of malignant tumours. 8th ed. Oxford: John Wiley & Sons; 2017.
   Google Scholar
• von Elm E, Altman DG, Egger M, et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. J Clin Epidemiol. 2008;61:344–349.
   PubMed Web of Science ®Google Scholar
• Bossuyt PM, Reitsma JB, Bruns DE, et al. Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative. Standards for Reporting of Diagnostic Accuracy. Clin Chem. 2003;49:1–6.
   PubMed Web of Science ®Google Scholar
• R Core Team. R: A language and environment for statistical computing. Vienna (Austria): R Foundation for Statistical Computing; 2017. Available from: https://www.R-project.org/
   Google Scholar
• Frank EH, Jr. rms: Regression Modeling Strategies. R package version 5.1-2. 2018. Available from: https://CRAN.R-project.org/package=rms
   Google Scholar
• Robin X, Turck N, Hainard A, et al. pROC: an open-source package for R and S + to analyze and compare ROC curves. BMC Bioinformatics. 2011;12:77.
   PubMed Web of Science ®Google Scholar
• Wickham H. ggplot2: elegant graphics for data analysis [Database]. New York: Springer-Verlag; 2009.
   Google Scholar
• Reid-Lombardo KM, Fridley BL, Bamlet WR, et al. Survival is associated with genetic variation in inflammatory pathway genes among patients with resected and unresected pancreatic cancer. Ann Surg. 2013;257:1096–1102.
   PubMed Web of Science ®Google Scholar
• Torres C, Linares A, Alejandre MJ, et al. Prognosis relevance of serum cytokines in pancreatic cancer. Biomed Res Int. 2015;2015:518284.
   PubMed Web of Science ®Google Scholar
• Wang L, Ma Q, Chen X, et al. Clinical significance of B7-H1 and B7-1 expressions in pancreatic carcinoma. World J Surg. 2010;34:1059–1065.
   PubMed Web of Science ®Google Scholar
• Zhao YP, Zhou PT, Ji WP, et al. Validation of N-glycan markers that improve the performance of CA19-9 in pancreatic cancer. Clin Exp Med. 2017;17:9–18.
   PubMed Web of Science ®Google Scholar
• Akimoto Y, Nouso K, Kato H, et al. Serum N-glycan profiles in patients with intraductal papillary mucinous neoplasms of the pancreas. Pancreatology. 2015;15:432–438.
   PubMed Web of Science ®Google Scholar
• Ohya A, Yamanoi K, Shimojo H, et al. Gastric gland mucin-specific O-glycan expression decreases with tumor progression from precursor lesions to pancreatic cancer. Cancer Sci. 2017;108:1897–1902.
   PubMed Web of Science ®Google Scholar
• Sharma A, Smyrk TC, Levy MJ, et al. Fasting blood glucose levels provide estimate of duration and progression of pancreatic cancer before diagnosis. Gastroenterology. 2018;155:490–500.e2.
   PubMed Web of Science ®Google Scholar
• Dias WB, Hart GW. O-GlcNAc modification in diabetes and Alzheimer's disease. Mol Biosyst. 2007;3:766–772.
   PubMed Web of Science ®Google Scholar